Gilead refuses to sell groundbreaking HIV prevention drug to MSF

Doctors Without Borders calls Gilead 'unconscionable' for refusing to sell HIV prevention drug to organization

In the latest dustup over a groundbreaking HIV prevention medicine, Doctors Without Borders has harshly criticized the manufacturer for refusing to sell its treatment directly to humanitarian organizations. The move came after months of talks in which Doctors Without Borders asked Gilead Sciences for a “limited” supply of lenacapavir. The drug has been in demand after studies showed a single set of injections every six months can offer virtually…

Gilead refuses to sell groundbreaking HIV prevention drug to MSF

Gilead refuses to sell groundbreaking HIV prevention drug to MSF Blocking humanitarian organizations from accessing a medical breakthrough puts vulnerable people across the world in danger. Kate Rankin March 30 2026, 8:59am Lenacapavir is an injectable version of pre-exposure prophylaxis (PrEP) that only needs to be administered two times per year — something that’s especially valuable for people who face barriers accessing daily or frequent m…